Sen. Roger Marshall (R-Kan.) moved Wednesday to prohibit federal grants going toward all “dangerous” gain-of-function ...

This Friday, February 28, marks five years since COVID-19 was first reported in Aotearoa New Zealand. At a population level, ...

The ChAdOx1 viral vector was developed at the University of Oxford and has been investigated as a potential vector for ...

The Visby Medical Respiratory Health Test is a disposable handheld RT-PCR–based assay for the detection and differentiation of SARS-CoV-2 and flu A/B.

Results of IMNN-101 Proof-of-Concept study demonstrate persistent immunogenicity in trial participants and further validate PlaCCine® ...

IMUNON (IMNN) announced new safety and immunogenicity data from ongoing analyses of results from the Company’s first Phase 1 proof-of-concept ...

The following is a summary of “Biomarker states and risk of death among individuals hospitalized with SARS-CoV-2 infection,” published in the February 2025 issue of BMC Infectious Diseases by ...

Doctor of Biological Sciences, Russian professor-virologist Alexander Shestopalov commented on reports of a new coronavirus ...

Scientists in China have found a new coronavirus in bats that could possibly infect humans, but the risk remains low for now.

Scientists at the Wuhan Institute of Virology in China have discovered a new lineage of a coronavirus in bats that can enter ...

NEW YORK – After acquiring Lucira Health in a bankruptcy auction in 2023, Pfizer has decided to shut down the business, a Pfizer spokesperson told GenomeWeb.

Long COVID is the chronic manifestation of lasting symptoms of SARS-CoV-2 infection that can last for at least 3 months, with shortness of breath and system inefficiency often remaining central issues ...